APP下载

针对性心理干预对难治性甲状腺癌靶向性治疗患者焦虑抑郁和生活质量的影响

2020-12-23朱俊玲吴军

中国医药导报 2020年28期
关键词:抑郁焦虑生活质量

朱俊玲 吴军

[摘要] 目的 探討针对性心理干预对难治性甲状腺癌靶向治疗患者焦虑抑郁及生活质量的影响。 方法 将2015年1月—2017年1月在华中科技大学同济医学院附属协和医院进行难治性甲状腺癌靶向治疗的60例患者按治疗时间记为单双数,随机平均分为干预组和对照组,每组30例。对照组采用一般健康教育,干预组在对照组的基础上进行针对性心理干预。采用焦虑自评量表(SAS)、抑郁自评量表(SDS)和欧洲癌症研究治疗组织癌症生命质量问卷(EORTC)QLQ-C30(v3.0)评价患者焦虑抑郁和生活质量。 结果 干预前,两组SAS、SDS及EORTC QLQ-C30(v3.0)比较,差异无统计学意义(P > 0.05)。干预后,干预组SAS、SDS均降低,且均低于对照组,差异有统计学意义(P < 0.05),对照组SDS评分低于干预前,差异有统计学意义(P < 0.05);干预组EORTC QLQ-C30问卷中躯体功能、角色、情绪、社会、总健康水平、疲倦、疼痛、气促、失眠与干预前比较,差异均有统计学意义(均P < 0.05),且EORTC QLQ-C30问卷中除经济困难与对照组比较,差异无统计学意义(P > 0.05),其余指标比较,差异均有统计学意义(均P < 0.05)。 结论 针对性心理干预可以改善难治性甲状腺癌靶向治疗患者的焦虑抑郁和生活质量。

[关键词] 难治性甲状腺癌;靶向治疗;针对性心理干预;焦虑;抑郁;生活质量

[中图分类号] R473.74          [文献标识码] A          [文章编号] 1673-7210(2020)10(a)-0165-04

Effect of targeted psychological intervention on anxiety, depression and quality of life in patients with refractory thyroid carcinoma targeted therapy

ZHU Junling1   WU Jun2

1.Department of Breast and Thyroid Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, Wuhan   430023, China; 2.Department of Nursing, the People′s Hospital of Kaizhou District. CQ, Chongqing   405400, China

[Abstract] Objective To investigate the effect of targeted psychological intervention on anxiety, depression and quality of life in patients with refractory thyroid carcinoma targeted therapy. Methods A total of 60 patients who received targeted therapy for refractory thyroid cancer in Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, from January 2015 to January 2017 were recorded as odd and even numbers according to the treatment time, they were randomly divided into the intervention group and the control group, with 30 patients in each group. The control group adopted general health education, and the intervention group carried out targeted psychological intervention on the basis of the control group. Anxiety, depression and quality of life were evaluated by the self-rating anxiety scale (SAS), self-rating depression scale (SDS) and the cancer quality of life questionnaire European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30 (V3.0). Results Before intervention, there were no significant differences in SAS, SDS and EORTC QLQ-C30 (v3.0) between the two groups (P > 0.05). After intervention, SAS and SDS in the intervention group were all decreased, and the differences were statistically significant (P < 0.05); SDS score in the control group was lower than that before intervention, and the difference was statistically significant (P < 0.05). Physical function, role, emotion, society, total health level, fatigue, pain, shortness of breath, and insomnia in the intervention group were statistically significant (all P < 0.05). In the EORTC QLQ-C30 questionnaire, there was no statistically significant difference (P > 0.05) except for the economic difficulties and the comparison with the control group, and the other indicators showed statistically significant differences (all P < 0.05). Conclusion Targeted psychological intervention can improve anxiety, depression and quality of life in patients with refractory thyroid cancer targeted therapy.

[Key words] Refractory thyroid carcinoma; Targeted therapy; Targeted psychological intervention; Anxiety; Depression; Quality of life

难治性甲状腺癌(refractory thyroid carcinoma,RTC)是10%~15%分化型甲状腺癌(differentiated thyroid carcinoma,DTC)、甲状腺髓样癌(medullary thyroid carcinoma,MTC)和甲状腺未分化癌(anaplastic thyroid carcinoma,ATC)治疗后复发的2/3并出现远处转移及碘抵抗的甲状腺癌[1]。RTC靶向治疗实验可延长患者无进展存活期[2-3],但容易出现严重的不良事件(adverse events,AEs),常见有皮肤损害、手足综合征(76%)、腹泻(45%~68%)、体重减轻(46%)、高血压(40%)、恶心呕吐(23%~37%)、蛋白尿(26%)[4-6],AEs使66%的患者需减小剂量,18%须暂停治疗[2,7]。针对AEs的干预相对滞后及靶向治疗费用昂贵等降低了患者依从性,明显影响了RTC治疗。研究表明[8-9]心理干预在甲状腺癌患者的治疗中效果较好,但未见RTC靶向治疗患者的心理干预,故本研究将其进行报道如下:

1 对象与方法

1.1 研究对象

登录APP查看全文

猜你喜欢

抑郁焦虑生活质量
个体化心理干预对妊娠呕吐孕妇焦虑抑郁的影响
循证护理策略对乳腺癌患者生存质量的影响评价
护理干预对突发性耳聋患者的影响
围绝经期综合征妇女行护理干预后生活质量的变化研究
产前个性化心理护理对初产妇焦虑、抑郁心理及分娩方式的影响
膳食纤维制剂对老年便秘患者疗效及生活质量的影响
社区在册糖尿病患者的生活质量及影响因素分析
德俄“焦虑”波兰右翼新总统